GLP-1 receptor agonists for obesity: eligibility across 99 countries

Sang Gune K Yoo, Felix Teufel, Michaela Theilmann, Yajuan Si, Elhadji A Toure, Krishna Aryal, Till Bärnighausen, Abdul Bait, Marta Barreto, Pascal Bovet, Luisa C C Brant, Sarah Cuschieri, Albertino Damasceno, Farshad Farzadfar, Asher Fawwad, Pascal Geldsetzer, Ian R Hambleton, Corine Houehanou, Christina Howitt, Jutta J⊘rgensen, Juan P González-Rivas, Demetre Labadarios, Maja Marcus, Joao Martins, Omar Mwalim, Ramfis Nieto-Martínez, Augustine N Odili, Binur Orazumbekova, Gastón Perman, Sarah Quesnel-Crooks, Sahar Saeedi Moghaddam, Ronel Sewpal, Mafalda Sousa-Uva, Mubarak A Sulola, Kavita Venkataraman, Sebastian Vollmer, Sim Xueling, Rifat Atun, José R Banegas, Juan V A Franco, Clare Arnott, Nomathemba Chandiwana, Mark D Huffman, Justine Davies, Mohammed K Ali, David Flood, Jennifer Manne-Goehler

Open source

DOI: 10.1016/s2213-8587(25)00356-0
Published: 2026-02
Container: The Lancet Diabetes & Endocrinology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2213-8587-25-00356-0,
  title = {GLP-1 receptor agonists for obesity: eligibility across 99 countries},
  author = {Sang Gune K Yoo and Felix Teufel and Michaela Theilmann and Yajuan Si and Elhadji A Toure and Krishna Aryal and Till Bärnighausen and Abdul Bait and Marta Barreto and Pascal Bovet and Luisa C C Brant and Sarah Cuschieri and Albertino Damasceno and Farshad Farzadfar and Asher Fawwad and Pascal Geldsetzer and Ian R Hambleton and Corine Houehanou and Christina Howitt and Jutta J⊘rgensen and Juan P González-Rivas and Demetre Labadarios and Maja Marcus and Joao Martins and Omar Mwalim and Ramfis Nieto-Martínez and Augustine N Odili and Binur Orazumbekova and Gastón Perman and Sarah Quesnel-Crooks and Sahar Saeedi Moghaddam and Ronel Sewpal and Mafalda Sousa-Uva and Mubarak A Sulola and Kavita Venkataraman and Sebastian Vollmer and Sim Xueling and Rifat Atun and José R Banegas and Juan V A Franco and Clare Arnott and Nomathemba Chandiwana and Mark D Huffman and Justine Davies and Mohammed K Ali and David Flood and Jennifer Manne-Goehler},
  year = {2026},
  journal = {The Lancet Diabetes \&amp; Endocrinology},
  doi = {10.1016/s2213-8587(25)00356-0},
  url = {https://doi.org/10.1016/s2213-8587(25)00356-0}
}

RIS

TY  - JOUR
TI  - GLP-1 receptor agonists for obesity: eligibility across 99 countries
AU  - Sang Gune K Yoo
AU  - Felix Teufel
AU  - Michaela Theilmann
AU  - Yajuan Si
AU  - Elhadji A Toure
AU  - Krishna Aryal
AU  - Till Bärnighausen
AU  - Abdul Bait
AU  - Marta Barreto
AU  - Pascal Bovet
AU  - Luisa C C Brant
AU  - Sarah Cuschieri
AU  - Albertino Damasceno
AU  - Farshad Farzadfar
AU  - Asher Fawwad
AU  - Pascal Geldsetzer
AU  - Ian R Hambleton
AU  - Corine Houehanou
AU  - Christina Howitt
AU  - Jutta J⊘rgensen
AU  - Juan P González-Rivas
AU  - Demetre Labadarios
AU  - Maja Marcus
AU  - Joao Martins
AU  - Omar Mwalim
AU  - Ramfis Nieto-Martínez
AU  - Augustine N Odili
AU  - Binur Orazumbekova
AU  - Gastón Perman
AU  - Sarah Quesnel-Crooks
AU  - Sahar Saeedi Moghaddam
AU  - Ronel Sewpal
AU  - Mafalda Sousa-Uva
AU  - Mubarak A Sulola
AU  - Kavita Venkataraman
AU  - Sebastian Vollmer
AU  - Sim Xueling
AU  - Rifat Atun
AU  - José R Banegas
AU  - Juan V A Franco
AU  - Clare Arnott
AU  - Nomathemba Chandiwana
AU  - Mark D Huffman
AU  - Justine Davies
AU  - Mohammed K Ali
AU  - David Flood
AU  - Jennifer Manne-Goehler
PY  - 2026
JO  - The Lancet Diabetes &amp; Endocrinology
DO  - 10.1016/s2213-8587(25)00356-0
UR  - https://doi.org/10.1016/s2213-8587(25)00356-0
ER  -

APA

Yoo, S. G. K., Teufel, F., Theilmann, M., Si, Y., Toure, E. A., Aryal, K., Bärnighausen, T., Bait, A., Barreto, M., Bovet, P., Brant, L. C. C., Cuschieri, S., Damasceno, A., Farzadfar, F., Fawwad, A., Geldsetzer, P., Hambleton, I. R., Houehanou, C., Howitt, C., J⊘rgensen, J., González-Rivas, J. P., Labadarios, D., Marcus, M., Martins, J., Mwalim, O., Nieto-Martínez, R., Odili, A. N., Orazumbekova, B., Perman, G., Quesnel-Crooks, S., Moghaddam, S. S., Sewpal, R., Sousa-Uva, M., Sulola, M. A., Venkataraman, K., Vollmer, S., Xueling, S., Atun, R., Banegas, J. R., Franco, J. V. A., Arnott, C., Chandiwana, N., Huffman, M. D., Davies, J., Ali, M. K., Flood, D., & Manne-Goehler, J. (2026). GLP-1 receptor agonists for obesity: eligibility across 99 countries. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(25)00356-0

Source records

crossref · retrieved 2026-09-26T00:38:14.825Z